Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ARE 
Alexandria Real Estate Equities Inc (ARE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/01/2025: ARE (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
13 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $68.33
1 Year Target Price $68.33
| 3 | Strong Buy |
| 1 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -32.98% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/01/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.28B USD | Price to earnings Ratio - | 1Y Target Price 68.33 |
Price to earnings Ratio - | 1Y Target Price 68.33 | ||
Volume (30-day avg) 13 | Beta 1.32 | 52 Weeks Range 48.66 - 103.12 | Updated Date 12/1/2025 |
52 Weeks Range 48.66 - 103.12 | Updated Date 12/1/2025 | ||
Dividends yield (FY) 9.86% | Basic EPS (TTM) -2.47 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -13.44% | Operating Margin (TTM) 19.07% |
Management Effectiveness
Return on Assets (TTM) 1.07% | Return on Equity (TTM) -1.08% |
Valuation
Trailing PE - | Forward PE 16.69 | Enterprise Value 22651573916 | Price to Sales(TTM) 3.03 |
Enterprise Value 22651573916 | Price to Sales(TTM) 3.03 | ||
Enterprise Value to Revenue 7.6 | Enterprise Value to EBITDA 16.93 | Shares Outstanding 172825059 | Shares Floating 154013051 |
Shares Outstanding 172825059 | Shares Floating 154013051 | ||
Percent Insiders 0.94 | Percent Institutions 98.15 |
Upturn AI SWOT
Alexandria Real Estate Equities Inc
Company Overview
History and Background
Alexandria Real Estate Equities, Inc. (ARE) was founded in 1994. It pioneered the life science real estate niche and has grown to be a leading REIT focused on collaborative life science, agtech, and technology campuses in innovation clusters.
Core Business Areas
- Leasing: Leasing of properties to tenants in the life science, agtech, and technology industries.
- Development and Redevelopment: Development and redevelopment of properties to meet the evolving needs of tenants.
- Strategic Investments: Strategic investments in venture capital and other initiatives to support the life science ecosystem.
Leadership and Structure
The company is led by Joel S. Marcus, the Executive Chairman & Founder. Marc Bena is the CEO. The organizational structure includes departments for leasing, development, finance, legal, and investment management.
Top Products and Market Share
Key Offerings
- Lab Space: High-quality lab and office space designed for life science companies. ARE is a top provider in key life science clusters. Competitors: Boston Properties, Kilroy Realty, BioMed Realty.
- Agtech Facilities: Specialized facilities for agricultural technology companies, including greenhouses and research labs. Competitors: Gladstone Land Corporation, Farmland Partners Inc.
- Office Space: Office space within innovation clusters to support the broader ecosystem. Competitors: SL Green Realty, Vornado Realty Trust.
Market Dynamics
Industry Overview
The life science real estate market is driven by strong demand for research and development space, fueled by advancements in biotechnology, pharmaceuticals, and agtech. Demand is concentrated in specific innovation clusters.
Positioning
Alexandria is a leading REIT in the life science real estate niche, with a strong reputation for providing high-quality properties and fostering innovation ecosystems. Its competitive advantage lies in its deep industry expertise and established relationships.
Total Addressable Market (TAM)
The global life science real estate market is estimated to be worth hundreds of billions of dollars. Alexandria is well-positioned to capture a significant share of this market through its focus on key innovation clusters.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- High-quality portfolio
- Expertise in life science real estate
- Strategic locations in innovation clusters
- Experienced management team
Weaknesses
- Concentration in specific markets
- Exposure to tenant credit risk
- High development costs
- Susceptibility to interest rate fluctuations
Opportunities
- Expansion into new innovation clusters
- Development of new property types
- Strategic acquisitions
- Growth in the agtech market
- Increased demand for lab space
Threats
- Economic downturn
- Increased competition
- Changes in government regulations
- Rising interest rates
- Tenant bankruptcies
Competitors and Market Share
Key Competitors
- BXP
- KRC
- ARE.PA
Competitive Landscape
Alexandria has a competitive advantage due to its focus on the life science real estate niche and its established relationships with leading companies. However, it faces competition from larger REITs with more diversified portfolios.
Major Acquisitions
Seragon Biosciences Inc.
- Year: 2014
- Acquisition Price (USD millions): 28
- Strategic Rationale: Enhanced Alexandria's strategic land holdings in key cluster locations. Allowed the development of world-class life science facilities.
Growth Trajectory and Initiatives
Historical Growth: Alexandria has demonstrated strong growth over the past decade, driven by increasing demand for life science real estate and strategic acquisitions.
Future Projections: Analyst estimates project continued growth for Alexandria, driven by expansion into new markets and development of new properties.
Recent Initiatives: Recent initiatives include expansion into new innovation clusters, development of new agtech facilities, and strategic investments in venture capital.
Summary
Alexandria Real Estate Equities is a strong company due to its specialized focus on life science real estate and strategic locations. Its expertise in the industry provides a competitive edge, but its concentration in specific markets and exposure to tenant credit risk are weaknesses. Successfully expanding into new markets and managing development costs are critical for future growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is based on estimated values and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alexandria Real Estate Equities Inc
Exchange NYSE | Headquaters Pasadena, CA, United States | ||
IPO Launch date 1997-05-27 | CEO & Chief Investment Officer Mr. Peter M. Moglia | ||
Sector Real Estate | Industry REIT - Office | Full time employees 552 | Website https://www.are.com |
Full time employees 552 | Website https://www.are.com | ||
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of September 30, 2025, Alexandria has a total market capitalization of $27.8 billion and an asset base in North America that includes 39.1 million RSF of operating properties and 4.2 million RSF of Class A/A+ properties undergoing construction and one 100% pre-leased committed near-term project expected to commence construction in the next year. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.